Key result
Wearable FSR device accurately measures PWV against the gold standard with 0.03 m/s mean error.
Why the study?
The widespread adoption of pulse wave velocity monitoring for continuous cardiovascular assessment remains limited by the absence of wearable devices suitable for continuous use.
Does a wearable FSR-based device accurately measure Pulse Wave Velocity compared to the clinical gold standard SphygmoCor in voluntary participants?
Does a wearable FSR-based device accurately measure Pulse Wave Velocity compared to the clinical gold standard SphygmoCor in voluntary participants?
A novel wearable device using Force Sensing Resistors accurately measures Pulse Wave Velocity with near-zero mean error compared to the clinical gold standard, enabling continuous cardiovascular monitoring.
Supports ambulatory PWV monitoring in clinical care; extends research into real-world longitudinal arterial stiffness assessment.
The rising average age in advanced economies is driving an increasingly urgent demand for technological solutions to monitor population health. Given that cardiovascular diseases remain the leading cause of mortality worldwide, the continuous assessment of cardiovascular function has become critically important. In this context, Pulse Wave Velocity (PWV) analysis represents a valuable tool for cardiovascular evaluation. However, the widespread adoption of PWV monitoring remains limited by the absence of wearable devices suitable for continuous use. This work addresses this gap by developing a wearable PWV monitoring device based on Force Sensing Resistor (FSR) technology designed to ensure high wearability. This objective was achieved by creating a miniaturized Printed Circuit Board (PCB) integrating signal acquisition and conditioning circuitry and a Bluetooth Low Energy (BLE) module for wireless data transmission. The data were analyzed by extracting the fiducial point, known as intersect tangent point (ITP), for the estimation of Pulse Transit Time (PTT) and the subsequent calculation of PWV. The system was validated on a cohort of 101 voluntary participants by comparing the PWV values obtained with the proposed device against those measured using the clinical gold standard, SphygmoCor. The results demonstrate a strong correlation between the two measurement systems, with a mean error close to zero 0.03 m/s) and a standard deviation of 1.03 m/s). These findings confirm the reliability and accuracy of the proposed solution in a clinical context.
No takes yet. Share an insight, caveat, or question.
Sanginario et al. (2026) studied this question. A novel wearable Force Sensing Resistor device accurately measured Pulse Wave Velocity against the clinical gold standard, yielding a mean error of 0.03 m/s and a standard deviation of 1.03 m/s.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: